glp 1 gip gcg receptor agonist GLP-1 Orals and Multi-Agonists: Advancing Next-Gen Weight Loss Therapies with Humanized Models Dual GLP-1/GIP receptor agonists mechanism
Description
Rao SS et al
Ozempic has demonstrated robust efficacy in reducing HbA1c (average blood sugars over the past 3 months), with some studies suggesting it may reduce HbA1c by up to 1.8%
GLP-1 use was not linked to increased risk for poor postoperative outcomes
10.1053/j.ackd.2012.12.006 [DOI] [PubMed] [Google Scholar] 17
Providing better support, especially in the initial phase of treatments such as GLP-1s, can greatly improve the user experience, reduce anxiety and help users adhere to their treatment plans
